Robert Ang, M.B.B.S
2020
In 2020, Robert Ang, M.B.B.S earned a total compensation of $2.8M as President and Chief Executive Officer at Vor Biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $211,200 |
|---|---|
| Option Awards | $1,619,356 |
| Salary | $424,173 |
| Other | $500,015 |
| Total | $2,754,744 |
MBBS received $1.6M in option awards, accounting for 59% of the total pay in 2020.
MBBS also received $211.2K in non-equity incentive plan, $424.2K in salary and $500K in other compensation.
Rankings
In 2020, Robert Ang, M.B.B.S' compensation ranked 4,186th out of 13,090 executives tracked by ExecPay. In other words, MBBS earned more than 68.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,186 out of 13,090 | 68th |
Division Manufacturing | 1,689 out of 5,621 | 70th |
Major group Chemicals And Allied Products | 648 out of 2,254 | 71st |
Industry group Drugs | 554 out of 1,954 | 72nd |
Industry Biological Products, Except Diagnostic Substances | 128 out of 411 | 69th |
Source: SEC filing on April 28, 2022.
MBBS' colleagues
We found two more compensation records of executives who worked with Robert Ang, M.B.B.S at Vor Biopharma in 2020.